A Comparative Evaluation of Three Diagnostic Assays for the Detection of Human Monkeypox
Viruses · 2024
DOI: 10.3390/v16081286 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Viruses, 2024. Verfasst von Jing Qu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Laboratory, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Monkeypox virus, Sensitivity and Specificity. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, Sanming Project of Medicine in Shenzhen.
Abstract (Originalsprache)
Accurate and early diagnosis of monkeypox virus (MPXV) is crucial for controlling epidemics and treating affected individuals promptly. This study aimed to assess the analytical and clinical performance of the MolecisionTM Monkeypox Virus qPCR Assay, Biorain Monkeypox Virus ddPCR Assay, and MAGLUMI® Monkeypox Virus Ag (chemiluminescence immunoassay, CLIA) Assay. Additionally, it aimed to compare the clinical application of antigen and nucleic acid assays to offer insights into using commercial monkeypox assay kits. Specimens from 117 clinical patients, serial diluted virus cell culture supernatant, and artificially created positive samples were tested to evaluate the performance of these assay kits for MPXV diagnostics. The Biorain Monkeypox Virus ddPCR Assay had a limit of detection (LoD) of 3.89 CCID50/mL, while the MolecisionTM Monkeypox Virus qPCR Assay had an LoD of 15.55 CCID50/mL. The MAGLUMI® Monkeypox Virus Ag (CLIA) Assay had an LoD of 0.500 pg/mL. The accuracy of the MolecisionTM Monkeypox Virus qPCR Assay was comparable to the Biorain Monkeypox Virus ddPCR Assay, and the MAGLUMI® Monkeypox Virus Ag (CLIA) Assay demonstrated high sensitivity. The specificity of all three MPXV diagnostic assays for clinical specimens with potential cross-reacting substances was 100%. In conclusion, this study provides valuable insights into the clinical application of monkeypox assays, supporting efforts to mitigate and control the spread of monkeypox.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology Laboratory, Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China.
- Research & Development Department, Shenzhen New Industries Biomedical Engineering Co., Ltd., (Snibe), Shenzhen 518122, China.
- Shenzhen Biorain Biotechnology Co., Ltd., Shenzhen 518122, China.
- National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
ORCID-Profile: Bo Peng
Förderung
- Shenzhen Science and Technology Program
- Sanming Project of Medicine in Shenzhen
Zitieren
APA
Qu, J., Zhang, X., Liu, K., Li, Y., Wang, T., Fang, Z., Chen, C., Tan, X., Lin, Y., Xu, Q., Yang, Y., Wang, W., Huang, M., Guo, S., Chen, Z., Rao, W., Shi, X., & Peng, B. (2024). A Comparative Evaluation of Three Diagnostic Assays for the Detection of Human Monkeypox. Viruses. https://doi.org/10.3390/v16081286
Vancouver
Qu J, Zhang X, Liu K, Li Y, Wang T, Fang Z, et al. A Comparative Evaluation of Three Diagnostic Assays for the Detection of Human Monkeypox. Viruses. 2024. doi:10.3390/v16081286
BibTeX
@article{Qu2024,
author = {Qu, Jing and Zhang, Xiaomin and Liu, Kun and Li, You and Wang, Ting and Fang, Zhonggang and Chen, Cheng and Tan, Xiao and Lin, Ying and Xu, Qing and Yang, Yan and Wang, Wanqing and Huang, Manyu and Guo, Shiliang and Chen, Ziqiu and Rao, Wei and Shi, Xiaolu and Peng, Bo},
title = {A Comparative Evaluation of Three Diagnostic Assays for the Detection of Human Monkeypox},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16081286}
}
EUVIMED